Medical Care
Global Drugs for Osteoarthritis Pain Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 23, 25
- ID: 322775
- Pages: 147
- Figures: 148
- Views: 3
In 2024, the global market size of Drugs for Osteoarthritis Pain was estimated to be worth US$ 10350 million and is forecast to reach approximately US$ 15380 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Osteoarthritis Pain.
The Drugs for Osteoarthritis Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Osteoarthritis Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Osteoarthritis Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Segment by Type
Oral
Injection
External
Segment by Application
Medical Care
Personal Care
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Drugs for Osteoarthritis Pain in global and regional level.
Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Osteoarthritis Pain revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Osteoarthritis Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Osteoarthritis Pain.
The Drugs for Osteoarthritis Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Osteoarthritis Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Osteoarthritis Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Segment by Type
Oral
Injection
External
Segment by Application
Medical Care
Personal Care
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Drugs for Osteoarthritis Pain in global and regional level.
Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Osteoarthritis Pain revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Drugs for Osteoarthritis Pain Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drugs for Osteoarthritis Pain Market Size Estimates and Forecasts
2.2 Drugs for Osteoarthritis Pain Market Size by Region: 2024 Versus 2031
2.2.1 Global Drugs for Osteoarthritis Pain Revenue by Region: 2020-2025
2.2.2 Global Drugs for Osteoarthritis Pain Revenue Forecast by Region (2026-2031)
2.2.3 Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Type (2020-2031)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Drugs for Osteoarthritis Pain Revenue by Application (2020-2031)
3.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Oral of Drugs for Osteoarthritis Pain Revenue Market Share by Application
3.3.2 Injection of Drugs for Osteoarthritis Pain Revenue Market Share by Application
3.3.3 External of Drugs for Osteoarthritis Pain Revenue Market Share by Application
4 Global Drugs for Osteoarthritis Pain by Company
4.1 Global Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
4.2 Global Drugs for Osteoarthritis Pain Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Drugs for Osteoarthritis Pain Companies around the World: Ranking by Revenue
4.3.2 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Drugs for Osteoarthritis Pain Companies Headquarters & Product Type
4.4.1 Global Drugs for Osteoarthritis Pain Companies Headquarters
4.4.2 Date of International Companies Enter into Drugs for Osteoarthritis Pain Market
4.4.3 Global Drugs for Osteoarthritis Pain Companies Product & Service
4.4.4 Oral Revenue Market Share of Drugs for Osteoarthritis Pain by Company
4.4.5 Injection Revenue Market Share of Drugs for Osteoarthritis Pain by Company
4.4.6 External Revenue Market Share of Drugs for Osteoarthritis Pain by Company
4.5 Global Drugs for Osteoarthritis Pain Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer
5.1.1 Pfizer Corporation Information
5.1.2 Pfizer Description, Business Overview
5.1.3 Pfizer Drugs for Osteoarthritis Pain Products Offered
5.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.1.6 Pfizer Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.1.7 Pfizer Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.1.8 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Corporation Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Products Offered
5.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.2.6 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.2.7 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Corporation Information
5.3.2 GlaxoSmithKline Description, Business Overview
5.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Products Offered
5.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.3.5 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.3.6 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.3.7 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.3.8 GlaxoSmithKline Recent Developments
5.4 Bayer
5.4.1 Bayer Corporation Information
5.4.2 Bayer Description, Business Overview
5.4.3 Bayer Drugs for Osteoarthritis Pain Products Offered
5.4.4 Bayer Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.4.5 Bayer Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.4.6 Bayer Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.4.7 Bayer Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.4.8 Bayer Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Corporation Information
5.5.2 Eli Lilly Description, Business Overview
5.5.3 Eli Lilly Drugs for Osteoarthritis Pain Products Offered
5.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.5.5 Eli Lilly Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.5.6 Eli Lilly Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.5.7 Eli Lilly Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.5.8 Eli Lilly Recent Developments
5.6 Novartis
5.6.1 Novartis Corporation Information
5.6.2 Novartis Description, Business Overview
5.6.3 Novartis Drugs for Osteoarthritis Pain Products Offered
5.6.4 Novartis Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.6.5 Novartis Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.6.6 Novartis Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.6.7 Novartis Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.6.8 Novartis Recent Developments
5.7 Sanofi
5.7.1 Sanofi Corporation Information
5.7.2 Sanofi Description, Business Overview
5.7.3 Sanofi Drugs for Osteoarthritis Pain Products Offered
5.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.7.5 Sanofi Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.7.6 Sanofi Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.7.7 Sanofi Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.7.8 Sanofi Recent Developments
5.8 Horizon Pharma
5.8.1 Horizon Pharma Corporation Information
5.8.2 Horizon Pharma Description, Business Overview
5.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Products Offered
5.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.8.5 Horizon Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.8.6 Horizon Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.8.7 Horizon Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.8.8 Horizon Pharma Recent Developments
5.9 Abbott
5.9.1 Abbott Corporation Information
5.9.2 Abbott Description, Business Overview
5.9.3 Abbott Drugs for Osteoarthritis Pain Products Offered
5.9.4 Abbott Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.9.5 Abbott Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.9.6 Abbott Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.9.7 Abbott Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.9.8 Abbott Recent Developments
5.10 Mylan
5.10.1 Mylan Corporation Information
5.10.2 Mylan Description, Business Overview
5.10.3 Mylan Drugs for Osteoarthritis Pain Products Offered
5.10.4 Mylan Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.10.5 Mylan Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.10.6 Mylan Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.10.7 Mylan Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.10.8 Mylan Recent Developments
5.11 Daiichi Sankyo
5.11.1 Daiichi Sankyo Corporation Information
5.11.2 Daiichi Sankyo Description, Business Overview
5.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Products Offered
5.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.11.5 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.11.6 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.11.7 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.11.8 Daiichi Sankyo Recent Developments
5.12 TEVA
5.12.1 TEVA Corporation Information
5.12.2 TEVA Description, Business Overview
5.12.3 TEVA Drugs for Osteoarthritis Pain Products Offered
5.12.4 TEVA Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.12.5 TEVA Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.12.6 TEVA Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.12.7 TEVA Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.12.8 TEVA Recent Developments
5.13 Almatica Pharma
5.13.1 Almatica Pharma Corporation Information
5.13.2 Almatica Pharma Description, Business Overview
5.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Products Offered
5.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.13.5 Almatica Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.13.6 Almatica Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.13.7 Almatica Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.13.8 Almatica Pharma Recent Developments
5.14 Astellas Pharma
5.14.1 Astellas Pharma Corporation Information
5.14.2 Astellas Pharma Description, Business Overview
5.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Products Offered
5.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.14.5 Astellas Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.14.6 Astellas Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.14.7 Astellas Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.14.8 Astellas Pharma Recent Developments
5.15 Tide Pharmaceutical
5.15.1 Tide Pharmaceutical Corporation Information
5.15.2 Tide Pharmaceutical Description, Business Overview
5.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Products Offered
5.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.15.5 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.15.6 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.15.7 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.15.8 Tide Pharmaceutical Recent Developments
5.16 Iroko Pharmaceuticals
5.16.1 Iroko Pharmaceuticals Corporation Information
5.16.2 Iroko Pharmaceuticals Description, Business Overview
5.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Products Offered
5.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.16.5 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.16.6 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.16.7 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.16.8 Iroko Pharmaceuticals Recent Developments
5.17 Hengrui Pharmaceutical
5.17.1 Hengrui Pharmaceutical Corporation Information
5.17.2 Hengrui Pharmaceutical Description, Business Overview
5.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Products Offered
5.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.17.5 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.17.6 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.17.7 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.17.8 Hengrui Pharmaceutical Recent Developments
5.18 Abiogen Pharma
5.18.1 Abiogen Pharma Corporation Information
5.18.2 Abiogen Pharma Description, Business Overview
5.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Products Offered
5.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.18.5 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.18.6 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.18.7 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.18.8 Abiogen Pharma Recent Developments
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
6.2 North America Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
6.3 North America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
6.4 North America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
7.4 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
8 Europe
8.1 Europe Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
8.2 Europe Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
8.3 Europe Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
8.4 Europe Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
9.2 Latin America Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
9.3 Latin America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
9.4 Latin America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
10.4 Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Drugs for Osteoarthritis Pain Supply Chain Analysis
11.2 Drugs for Osteoarthritis Pain Key Raw Materials and Upstream Suppliers
11.3 Drugs for Osteoarthritis Pain Clients Analysis
11.4 Drugs for Osteoarthritis Pain Sales Channel and Sales Model Analysis
11.4.1 Drugs for Osteoarthritis Pain Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Drugs for Osteoarthritis Pain Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Drugs for Osteoarthritis Pain Distributors
12 Drugs for Osteoarthritis Pain Market Dynamics
12.1 Drugs for Osteoarthritis Pain Industry Trends
12.2 Drugs for Osteoarthritis Pain Market Drivers
12.3 Drugs for Osteoarthritis Pain Market Challenges
12.4 Drugs for Osteoarthritis Pain Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Drugs for Osteoarthritis Pain Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drugs for Osteoarthritis Pain Market Size Estimates and Forecasts
2.2 Drugs for Osteoarthritis Pain Market Size by Region: 2024 Versus 2031
2.2.1 Global Drugs for Osteoarthritis Pain Revenue by Region: 2020-2025
2.2.2 Global Drugs for Osteoarthritis Pain Revenue Forecast by Region (2026-2031)
2.2.3 Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Type (2020-2031)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Drugs for Osteoarthritis Pain Revenue by Application (2020-2031)
3.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Oral of Drugs for Osteoarthritis Pain Revenue Market Share by Application
3.3.2 Injection of Drugs for Osteoarthritis Pain Revenue Market Share by Application
3.3.3 External of Drugs for Osteoarthritis Pain Revenue Market Share by Application
4 Global Drugs for Osteoarthritis Pain by Company
4.1 Global Drugs for Osteoarthritis Pain Revenue by Company (2020-2025)
4.2 Global Drugs for Osteoarthritis Pain Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Drugs for Osteoarthritis Pain Companies around the World: Ranking by Revenue
4.3.2 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Drugs for Osteoarthritis Pain Companies Headquarters & Product Type
4.4.1 Global Drugs for Osteoarthritis Pain Companies Headquarters
4.4.2 Date of International Companies Enter into Drugs for Osteoarthritis Pain Market
4.4.3 Global Drugs for Osteoarthritis Pain Companies Product & Service
4.4.4 Oral Revenue Market Share of Drugs for Osteoarthritis Pain by Company
4.4.5 Injection Revenue Market Share of Drugs for Osteoarthritis Pain by Company
4.4.6 External Revenue Market Share of Drugs for Osteoarthritis Pain by Company
4.5 Global Drugs for Osteoarthritis Pain Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer
5.1.1 Pfizer Corporation Information
5.1.2 Pfizer Description, Business Overview
5.1.3 Pfizer Drugs for Osteoarthritis Pain Products Offered
5.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.1.6 Pfizer Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.1.7 Pfizer Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.1.8 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Corporation Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Products Offered
5.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.2.6 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.2.7 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Corporation Information
5.3.2 GlaxoSmithKline Description, Business Overview
5.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Products Offered
5.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.3.5 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.3.6 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.3.7 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.3.8 GlaxoSmithKline Recent Developments
5.4 Bayer
5.4.1 Bayer Corporation Information
5.4.2 Bayer Description, Business Overview
5.4.3 Bayer Drugs for Osteoarthritis Pain Products Offered
5.4.4 Bayer Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.4.5 Bayer Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.4.6 Bayer Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.4.7 Bayer Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.4.8 Bayer Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Corporation Information
5.5.2 Eli Lilly Description, Business Overview
5.5.3 Eli Lilly Drugs for Osteoarthritis Pain Products Offered
5.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.5.5 Eli Lilly Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.5.6 Eli Lilly Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.5.7 Eli Lilly Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.5.8 Eli Lilly Recent Developments
5.6 Novartis
5.6.1 Novartis Corporation Information
5.6.2 Novartis Description, Business Overview
5.6.3 Novartis Drugs for Osteoarthritis Pain Products Offered
5.6.4 Novartis Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.6.5 Novartis Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.6.6 Novartis Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.6.7 Novartis Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.6.8 Novartis Recent Developments
5.7 Sanofi
5.7.1 Sanofi Corporation Information
5.7.2 Sanofi Description, Business Overview
5.7.3 Sanofi Drugs for Osteoarthritis Pain Products Offered
5.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.7.5 Sanofi Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.7.6 Sanofi Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.7.7 Sanofi Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.7.8 Sanofi Recent Developments
5.8 Horizon Pharma
5.8.1 Horizon Pharma Corporation Information
5.8.2 Horizon Pharma Description, Business Overview
5.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Products Offered
5.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.8.5 Horizon Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.8.6 Horizon Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.8.7 Horizon Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.8.8 Horizon Pharma Recent Developments
5.9 Abbott
5.9.1 Abbott Corporation Information
5.9.2 Abbott Description, Business Overview
5.9.3 Abbott Drugs for Osteoarthritis Pain Products Offered
5.9.4 Abbott Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.9.5 Abbott Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.9.6 Abbott Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.9.7 Abbott Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.9.8 Abbott Recent Developments
5.10 Mylan
5.10.1 Mylan Corporation Information
5.10.2 Mylan Description, Business Overview
5.10.3 Mylan Drugs for Osteoarthritis Pain Products Offered
5.10.4 Mylan Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.10.5 Mylan Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.10.6 Mylan Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.10.7 Mylan Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.10.8 Mylan Recent Developments
5.11 Daiichi Sankyo
5.11.1 Daiichi Sankyo Corporation Information
5.11.2 Daiichi Sankyo Description, Business Overview
5.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Products Offered
5.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.11.5 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.11.6 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.11.7 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.11.8 Daiichi Sankyo Recent Developments
5.12 TEVA
5.12.1 TEVA Corporation Information
5.12.2 TEVA Description, Business Overview
5.12.3 TEVA Drugs for Osteoarthritis Pain Products Offered
5.12.4 TEVA Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.12.5 TEVA Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.12.6 TEVA Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.12.7 TEVA Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.12.8 TEVA Recent Developments
5.13 Almatica Pharma
5.13.1 Almatica Pharma Corporation Information
5.13.2 Almatica Pharma Description, Business Overview
5.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Products Offered
5.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.13.5 Almatica Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.13.6 Almatica Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.13.7 Almatica Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.13.8 Almatica Pharma Recent Developments
5.14 Astellas Pharma
5.14.1 Astellas Pharma Corporation Information
5.14.2 Astellas Pharma Description, Business Overview
5.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Products Offered
5.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.14.5 Astellas Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.14.6 Astellas Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.14.7 Astellas Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.14.8 Astellas Pharma Recent Developments
5.15 Tide Pharmaceutical
5.15.1 Tide Pharmaceutical Corporation Information
5.15.2 Tide Pharmaceutical Description, Business Overview
5.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Products Offered
5.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.15.5 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.15.6 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.15.7 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.15.8 Tide Pharmaceutical Recent Developments
5.16 Iroko Pharmaceuticals
5.16.1 Iroko Pharmaceuticals Corporation Information
5.16.2 Iroko Pharmaceuticals Description, Business Overview
5.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Products Offered
5.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.16.5 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.16.6 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.16.7 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.16.8 Iroko Pharmaceuticals Recent Developments
5.17 Hengrui Pharmaceutical
5.17.1 Hengrui Pharmaceutical Corporation Information
5.17.2 Hengrui Pharmaceutical Description, Business Overview
5.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Products Offered
5.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.17.5 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.17.6 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.17.7 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.17.8 Hengrui Pharmaceutical Recent Developments
5.18 Abiogen Pharma
5.18.1 Abiogen Pharma Corporation Information
5.18.2 Abiogen Pharma Description, Business Overview
5.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Products Offered
5.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue and Gross Margin (2020-2025)
5.18.5 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue by Product in 2024
5.18.6 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue by Application in 2024
5.18.7 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue by Geographic Area in 2024
5.18.8 Abiogen Pharma Recent Developments
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
6.2 North America Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
6.3 North America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
6.4 North America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
7.4 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
8 Europe
8.1 Europe Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
8.2 Europe Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
8.3 Europe Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
8.4 Europe Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
9.2 Latin America Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
9.3 Latin America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
9.4 Latin America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Drugs for Osteoarthritis Pain Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Type (2020-2025)
10.4 Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Drugs for Osteoarthritis Pain Supply Chain Analysis
11.2 Drugs for Osteoarthritis Pain Key Raw Materials and Upstream Suppliers
11.3 Drugs for Osteoarthritis Pain Clients Analysis
11.4 Drugs for Osteoarthritis Pain Sales Channel and Sales Model Analysis
11.4.1 Drugs for Osteoarthritis Pain Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Drugs for Osteoarthritis Pain Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Drugs for Osteoarthritis Pain Distributors
12 Drugs for Osteoarthritis Pain Market Dynamics
12.1 Drugs for Osteoarthritis Pain Industry Trends
12.2 Drugs for Osteoarthritis Pain Market Drivers
12.3 Drugs for Osteoarthritis Pain Market Challenges
12.4 Drugs for Osteoarthritis Pain Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Drugs for Osteoarthritis Pain Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Drugs for Osteoarthritis Pain Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drugs for Osteoarthritis Pain Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Drugs for Osteoarthritis Pain Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 11. Drugs for Osteoarthritis Pain Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Drugs for Osteoarthritis Pain Players by Revenue (US$ Million) in 2024
Table 13. Global Drugs for Osteoarthritis Pain Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Table 15. Global Drugs for Osteoarthritis Pain Companies Headquarters
Table 16. Date of International Companies Enter into Drugs for Osteoarthritis Pain Market
Table 17. Global Drugs for Osteoarthritis Pain Companies Product & Service
Table 18. Global Drugs for Osteoarthritis Pain Mergers & Acquisitions, Expansion Plans
Table 19. Pfizer Corporation Information
Table 20. Pfizer Description and Business Overview
Table 21. Pfizer Drugs for Osteoarthritis Pain Product
Table 22. Pfizer Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Pfizer Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 24. Pfizer Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 25. Pfizer Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 26. Pfizer Recent Developments
Table 27. Johnson & Johnson Corporation Information
Table 28. Johnson & Johnson Description and Business Overview
Table 29. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 30. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Johnson & Johnson Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 32. Johnson & Johnson Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 33. Johnson & Johnson Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 34. Johnson & Johnson Recent Developments
Table 35. GlaxoSmithKline Corporation Information
Table 36. GlaxoSmithKline Description and Business Overview
Table 37. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 38. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. GlaxoSmithKline Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 40. GlaxoSmithKline Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 41. GlaxoSmithKline Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 42. GlaxoSmithKline Recent Developments
Table 43. Bayer Corporation Information
Table 44. Bayer Description and Business Overview
Table 45. Bayer Drugs for Osteoarthritis Pain Product
Table 46. Bayer Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Bayer Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 48. Bayer Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 49. Bayer Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 50. Bayer Recent Developments
Table 51. Eli Lilly Corporation Information
Table 52. Eli Lilly Description and Business Overview
Table 53. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 54. Eli Lilly Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Eli Lilly Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 56. Eli Lilly Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 57. Eli Lilly Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 58. Eli Lilly Recent Developments
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Drugs for Osteoarthritis Pain Product
Table 62. Novartis Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Novartis Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 64. Novartis Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 65. Novartis Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 66. Novartis Recent Developments
Table 67. Sanofi Corporation Information
Table 68. Sanofi Description and Business Overview
Table 69. Sanofi Drugs for Osteoarthritis Pain Product
Table 70. Sanofi Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Sanofi Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 72. Sanofi Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 73. Sanofi Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 74. Sanofi Recent Developments
Table 75. Horizon Pharma Corporation Information
Table 76. Horizon Pharma Description and Business Overview
Table 77. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 78. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Horizon Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 80. Horizon Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 81. Horizon Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 82. Horizon Pharma Recent Developments
Table 83. Abbott Corporation Information
Table 84. Abbott Description and Business Overview
Table 85. Abbott Drugs for Osteoarthritis Pain Product
Table 86. Abbott Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Abbott Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 88. Abbott Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 89. Abbott Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 90. Abbott Recent Developments
Table 91. Mylan Corporation Information
Table 92. Mylan Description and Business Overview
Table 93. Mylan Drugs for Osteoarthritis Pain Product
Table 94. Mylan Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Mylan Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 96. Mylan Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 97. Mylan Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 98. Mylan Recent Developments
Table 99. Daiichi Sankyo Corporation Information
Table 100. Daiichi Sankyo Description and Business Overview
Table 101. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 102. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Daiichi Sankyo Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 104. Daiichi Sankyo Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 105. Daiichi Sankyo Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 106. Daiichi Sankyo Recent Developments
Table 107. TEVA Corporation Information
Table 108. TEVA Description and Business Overview
Table 109. TEVA Drugs for Osteoarthritis Pain Product
Table 110. TEVA Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. TEVA Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 112. TEVA Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 113. TEVA Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 114. TEVA Recent Developments
Table 115. Almatica Pharma Corporation Information
Table 116. Almatica Pharma Description and Business Overview
Table 117. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 118. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Almatica Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 120. Almatica Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 121. Almatica Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 122. Almatica Pharma Recent Developments
Table 123. Astellas Pharma Corporation Information
Table 124. Astellas Pharma Description and Business Overview
Table 125. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 126. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Astellas Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 128. Astellas Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 129. Astellas Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 130. Astellas Pharma Recent Developments
Table 131. Tide Pharmaceutical Corporation Information
Table 132. Tide Pharmaceutical Description and Business Overview
Table 133. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 134. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Tide Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 136. Tide Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 137. Tide Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 138. Tide Pharmaceutical Recent Developments
Table 139. Iroko Pharmaceuticals Corporation Information
Table 140. Iroko Pharmaceuticals Description and Business Overview
Table 141. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 142. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Iroko Pharmaceuticals Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 144. Iroko Pharmaceuticals Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 145. Iroko Pharmaceuticals Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 146. Iroko Pharmaceuticals Recent Developments
Table 147. Hengrui Pharmaceutical Corporation Information
Table 148. Hengrui Pharmaceutical Description and Business Overview
Table 149. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 150. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Hengrui Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 152. Hengrui Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 153. Hengrui Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 154. Hengrui Pharmaceutical Recent Developments
Table 155. Abiogen Pharma Corporation Information
Table 156. Abiogen Pharma Description and Business Overview
Table 157. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 158. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Abiogen Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 160. Abiogen Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 161. Abiogen Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 162. Abiogen Pharma Recent Developments
Table 163. North America Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 183. Drugs for Osteoarthritis Pain Key Raw Materials, Industry Status and Trend
Table 184. Drugs for Osteoarthritis Pain Key Raw Materials and Upstream Suppliers
Table 185. Drugs for Osteoarthritis Pain Clients Status and Trend
Table 186. Drugs for Osteoarthritis Pain Typical Clients
Table 187. Drugs for Osteoarthritis Pain Distributors
Table 188. Drugs for Osteoarthritis Pain Market Trends
Table 189. Drugs for Osteoarthritis Pain Market Drivers
Table 190. Drugs for Osteoarthritis Pain Market Challenges
Table 191. Drugs for Osteoarthritis Pain Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Product Picture
Figure 2. Global Drugs for Osteoarthritis Pain Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. External Product Picture
Figure 7. Global Drugs for Osteoarthritis Pain Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application in 2024 & 2031
Figure 9. Medical Care
Figure 10. Personal Care
Figure 11. Drugs for Osteoarthritis Pain Report Years Considered
Figure 12. Global Drugs for Osteoarthritis Pain Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drugs for Osteoarthritis Pain Market Size (2020-2031) & (US$ Million)
Figure 14. Global Drugs for Osteoarthritis Pain Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2031)
Figure 16. Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Oral of Drugs for Osteoarthritis Pain Revenue Market Share by Application, 2024 VS 2031
Figure 19. Injection of Drugs for Osteoarthritis Pain Revenue Market Share by Application, 2024 VS 2031
Figure 20. External of Drugs for Osteoarthritis Pain Revenue Market Share by Application, 2024 VS 2031
Figure 21. Drugs for Osteoarthritis Pain Revenue Share by Company (2024)
Figure 22. Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Oral Revenue Proportion by Company in 2024
Figure 24. Injection Revenue Proportion by Company in 2024
Figure 25. External Revenue Proportion by Company in 2024
Figure 26. North America Drugs for Osteoarthritis Pain Revenue 2020-2031 (US$ Million)
Figure 27. North America Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 28. North America Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Drugs for Osteoarthritis Pain Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 33. Europe Drugs for Osteoarthritis Pain Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Country (2020-2031)
Figure 35. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 36. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Drugs for Osteoarthritis Pain Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Drugs for Osteoarthritis Pain Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 45. Drugs for Osteoarthritis Pain Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Drugs for Osteoarthritis Pain Raw Materials by Region in 2024
Figure 47. Drugs for Osteoarthritis Pain Distribution Channels
Figure 48. Global Drugs for Osteoarthritis Pain Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Drugs for Osteoarthritis Pain Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Drugs for Osteoarthritis Pain Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Drugs for Osteoarthritis Pain Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drugs for Osteoarthritis Pain Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Drugs for Osteoarthritis Pain Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 11. Drugs for Osteoarthritis Pain Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Drugs for Osteoarthritis Pain Players by Revenue (US$ Million) in 2024
Table 13. Global Drugs for Osteoarthritis Pain Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Table 15. Global Drugs for Osteoarthritis Pain Companies Headquarters
Table 16. Date of International Companies Enter into Drugs for Osteoarthritis Pain Market
Table 17. Global Drugs for Osteoarthritis Pain Companies Product & Service
Table 18. Global Drugs for Osteoarthritis Pain Mergers & Acquisitions, Expansion Plans
Table 19. Pfizer Corporation Information
Table 20. Pfizer Description and Business Overview
Table 21. Pfizer Drugs for Osteoarthritis Pain Product
Table 22. Pfizer Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Pfizer Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 24. Pfizer Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 25. Pfizer Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 26. Pfizer Recent Developments
Table 27. Johnson & Johnson Corporation Information
Table 28. Johnson & Johnson Description and Business Overview
Table 29. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 30. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Johnson & Johnson Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 32. Johnson & Johnson Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 33. Johnson & Johnson Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 34. Johnson & Johnson Recent Developments
Table 35. GlaxoSmithKline Corporation Information
Table 36. GlaxoSmithKline Description and Business Overview
Table 37. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 38. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. GlaxoSmithKline Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 40. GlaxoSmithKline Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 41. GlaxoSmithKline Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 42. GlaxoSmithKline Recent Developments
Table 43. Bayer Corporation Information
Table 44. Bayer Description and Business Overview
Table 45. Bayer Drugs for Osteoarthritis Pain Product
Table 46. Bayer Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Bayer Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 48. Bayer Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 49. Bayer Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 50. Bayer Recent Developments
Table 51. Eli Lilly Corporation Information
Table 52. Eli Lilly Description and Business Overview
Table 53. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 54. Eli Lilly Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Eli Lilly Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 56. Eli Lilly Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 57. Eli Lilly Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 58. Eli Lilly Recent Developments
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Drugs for Osteoarthritis Pain Product
Table 62. Novartis Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Novartis Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 64. Novartis Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 65. Novartis Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 66. Novartis Recent Developments
Table 67. Sanofi Corporation Information
Table 68. Sanofi Description and Business Overview
Table 69. Sanofi Drugs for Osteoarthritis Pain Product
Table 70. Sanofi Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Sanofi Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 72. Sanofi Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 73. Sanofi Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 74. Sanofi Recent Developments
Table 75. Horizon Pharma Corporation Information
Table 76. Horizon Pharma Description and Business Overview
Table 77. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 78. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Horizon Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 80. Horizon Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 81. Horizon Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 82. Horizon Pharma Recent Developments
Table 83. Abbott Corporation Information
Table 84. Abbott Description and Business Overview
Table 85. Abbott Drugs for Osteoarthritis Pain Product
Table 86. Abbott Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Abbott Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 88. Abbott Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 89. Abbott Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 90. Abbott Recent Developments
Table 91. Mylan Corporation Information
Table 92. Mylan Description and Business Overview
Table 93. Mylan Drugs for Osteoarthritis Pain Product
Table 94. Mylan Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Mylan Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 96. Mylan Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 97. Mylan Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 98. Mylan Recent Developments
Table 99. Daiichi Sankyo Corporation Information
Table 100. Daiichi Sankyo Description and Business Overview
Table 101. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 102. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Daiichi Sankyo Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 104. Daiichi Sankyo Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 105. Daiichi Sankyo Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 106. Daiichi Sankyo Recent Developments
Table 107. TEVA Corporation Information
Table 108. TEVA Description and Business Overview
Table 109. TEVA Drugs for Osteoarthritis Pain Product
Table 110. TEVA Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. TEVA Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 112. TEVA Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 113. TEVA Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 114. TEVA Recent Developments
Table 115. Almatica Pharma Corporation Information
Table 116. Almatica Pharma Description and Business Overview
Table 117. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 118. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Almatica Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 120. Almatica Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 121. Almatica Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 122. Almatica Pharma Recent Developments
Table 123. Astellas Pharma Corporation Information
Table 124. Astellas Pharma Description and Business Overview
Table 125. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 126. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Astellas Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 128. Astellas Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 129. Astellas Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 130. Astellas Pharma Recent Developments
Table 131. Tide Pharmaceutical Corporation Information
Table 132. Tide Pharmaceutical Description and Business Overview
Table 133. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 134. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Tide Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 136. Tide Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 137. Tide Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 138. Tide Pharmaceutical Recent Developments
Table 139. Iroko Pharmaceuticals Corporation Information
Table 140. Iroko Pharmaceuticals Description and Business Overview
Table 141. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 142. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Iroko Pharmaceuticals Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 144. Iroko Pharmaceuticals Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 145. Iroko Pharmaceuticals Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 146. Iroko Pharmaceuticals Recent Developments
Table 147. Hengrui Pharmaceutical Corporation Information
Table 148. Hengrui Pharmaceutical Description and Business Overview
Table 149. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 150. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Hengrui Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 152. Hengrui Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 153. Hengrui Pharmaceutical Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 154. Hengrui Pharmaceutical Recent Developments
Table 155. Abiogen Pharma Corporation Information
Table 156. Abiogen Pharma Description and Business Overview
Table 157. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 158. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Abiogen Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Product in 2024
Table 160. Abiogen Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Application in 2024
Table 161. Abiogen Pharma Revenue Proportion of Drugs for Osteoarthritis Pain by Geographic Area in 2024
Table 162. Abiogen Pharma Recent Developments
Table 163. North America Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Application (2020-2025) & (US$ Million)
Table 183. Drugs for Osteoarthritis Pain Key Raw Materials, Industry Status and Trend
Table 184. Drugs for Osteoarthritis Pain Key Raw Materials and Upstream Suppliers
Table 185. Drugs for Osteoarthritis Pain Clients Status and Trend
Table 186. Drugs for Osteoarthritis Pain Typical Clients
Table 187. Drugs for Osteoarthritis Pain Distributors
Table 188. Drugs for Osteoarthritis Pain Market Trends
Table 189. Drugs for Osteoarthritis Pain Market Drivers
Table 190. Drugs for Osteoarthritis Pain Market Challenges
Table 191. Drugs for Osteoarthritis Pain Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Product Picture
Figure 2. Global Drugs for Osteoarthritis Pain Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. External Product Picture
Figure 7. Global Drugs for Osteoarthritis Pain Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application in 2024 & 2031
Figure 9. Medical Care
Figure 10. Personal Care
Figure 11. Drugs for Osteoarthritis Pain Report Years Considered
Figure 12. Global Drugs for Osteoarthritis Pain Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drugs for Osteoarthritis Pain Market Size (2020-2031) & (US$ Million)
Figure 14. Global Drugs for Osteoarthritis Pain Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2031)
Figure 16. Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Oral of Drugs for Osteoarthritis Pain Revenue Market Share by Application, 2024 VS 2031
Figure 19. Injection of Drugs for Osteoarthritis Pain Revenue Market Share by Application, 2024 VS 2031
Figure 20. External of Drugs for Osteoarthritis Pain Revenue Market Share by Application, 2024 VS 2031
Figure 21. Drugs for Osteoarthritis Pain Revenue Share by Company (2024)
Figure 22. Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Oral Revenue Proportion by Company in 2024
Figure 24. Injection Revenue Proportion by Company in 2024
Figure 25. External Revenue Proportion by Company in 2024
Figure 26. North America Drugs for Osteoarthritis Pain Revenue 2020-2031 (US$ Million)
Figure 27. North America Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 28. North America Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Drugs for Osteoarthritis Pain Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 33. Europe Drugs for Osteoarthritis Pain Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Country (2020-2031)
Figure 35. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 36. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Drugs for Osteoarthritis Pain Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Drugs for Osteoarthritis Pain Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Application (2020-2025)
Figure 45. Drugs for Osteoarthritis Pain Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Drugs for Osteoarthritis Pain Raw Materials by Region in 2024
Figure 47. Drugs for Osteoarthritis Pain Distribution Channels
Figure 48. Global Drugs for Osteoarthritis Pain Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Drugs for Osteoarthritis Pain Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232